03 February 2019 | EventsNCIRS Seminar/Webinar for providers: Monday 18 Feb 2019 – Conversations with vaccine-hesitant parents: how the new SKAI website can helpRead the full article
The Weekly Jab newsletter is compiled by NCIRS to provide a summary of the latest resources, news, media, events, publications and career opportunities related to immunisation each week. It aims to keep immunisation professionals up to date with the latest information related to vaccination and vaccine preventable diseases.
Updates to NCIRS resources are communicated via The Weekly Jab as are all NCIRS events, including seminars, webinars and workshops.
At the time of subscription, applicants are asked to provide their full name, position, organisation they work for or represent and a brief outline of their involvement with immunisation. If the information received from the applicant meets the criteria, the subscription request is approved.
Weekly Jab subscribers also automatically added as members of the Australian Immunisation Professionals Network (NCIRS-AIP) discussion forum.
To subscribe to The Weekly Jab and NCIRS-AIP, please go to the subscription page and follow the instructions there. Subscribing implies acceptance of Terms and Conditions contained in the Guidelines for membership and operation.
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.